T-Reg Cell Kinetics, Stem Cell Transplant, REGALE
Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients Who Have Had Donor Marrow Grafts
|3||Enrolling by invitation||
Evaluation and Long-Term Follow-up of Patients With Inflammatory Disorders
Genetic Studies of Chronic Active Epstein-Barr Disease
|5||Active, not recruiting||
LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
† Study has passed its completion date and status has not been verified in more than two years.